Physician profile
Sameer Shah
NPI 1225266406
$10,110.47
in general payments reported to CMS, 2019-2025
46 companies · $826 in 2025
The $826 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,801 · 2020: $1,013 · 2021: $1,330 · 2022: $3,112 · 2023: $609 · 2024: $419 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,854.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,236.62 | 2021-2025 | Inceptiv, Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Medtronic USA, INC. | $1,425.48 | 2019-2020 | |
| Lilly USA, LLC | $550.67 | 2019-2023 | Reyvow, Emgality |
| Horizon Therapeutics Plc | $535.64 | 2019-2022 | |
| Abbvie INC. | $510.96 | 2021-2024 | Botox |
| Stryker Corporation | $441.67 | 2019-2024 | Multigen 2, Everest Spinal System |
| Supernus Pharmaceuticals, INC. | $388.53 | 2019-2021 | |
| Nevro Corp. | $291.47 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $243.63 | 2019-2021 | |
| Boston Scientific Corporation | $212.02 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $182.27 | 2020-2025 | Eterna, Proclaim |
| Ibsa Pharma INC. | $169.22 | 2021-2023 | Tirosint, Licart |
| Pfizer INC. | $161.14 | 2019-2023 | |
| Avanos Medical | $157.94 | 2019-2025 | Genvisc 850 Sodium Hyaluronate |
| Collegium Pharmaceutical, INC. | $150.25 | 2020-2021 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.